Pfizer Inc and BioNTech\u0027s vaccine was 73.2% effective in preventing COVID\u002D19 among children aged 6 months through 4 years, new data showed.
The Pfizer-BioNTech vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a similar immune response as in older age groups.Sign up to receive daily headline news from the Ottawa SUN, a division of Postmedia Network Inc.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails.
Most cases were caused by the Omicron BA.2 variant that was dominant in March and April, when the study was conducted.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer's COVID vaccine 73.2% effective in kids under fivePfizer Inc and BioNTech’s vaccine was 73.2% effective in preventing COVID-19 among children aged 6 months through 4 years, new data from the companies showed on Tuesday, two months after the U.S. rollout of the shots began for that age group
Read more »
Pfizer's COVID vaccine 73.2% effective in kids under 5, new data showsPfizer Inc and BioNTech\u0027s vaccine was 73.2% effective in preventing COVID\u002D19 among children aged 6 months through 4 years, new data showed.
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer asked U.S. regulators Monday to authorize its combination COVID\u002D19 vaccine that adds protection against the newest omicron relatives — a key step toward…
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer asked U.S. regulators Monday to authorize its combination COVID\u002D19 vaccine that adds protection against the newest omicron relatives — a key step toward…
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer asked U.S. regulators Monday to authorize its combination COVID\u002D19 vaccine that adds protection against the newest omicron relatives — a key step toward…
Read more »
Moderna to supply 12 million doses of Omicron COVID shot to CanadaModerna Inc said it will supply 12 million doses of its variant\u002Dadapted COVID\u002D19 shot that targets Omicron version of the virus to Canada.
Read more »